Monocarboxylate transporter (MCT) mediates the transport of γ-hydroxybutyrate in human kidney HK-2 cells

Pharmaceutical Research

Volumn 24, Issue 6, 2007, Pages 1067-1078

  Wang, Qi ^a   Lu, Ye ^a,b   Morris, Marilyn E ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

hydroxybutyrate; MCT; Monocarboxylate transporters; Renal transport; Transporters

Indexed keywords

4 HYDROXYBUTYRIC ACID; LACTIC ACID; MONOCARBOXYLATE TRANSPORTER; MONOCARBOXYLATE TRANSPORTER 1; MONOCARBOXYLATE TRANSPORTER 2; MONOCARBOXYLATE TRANSPORTER 4; SMALL INTERFERING RNA;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIFFUSION; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; HUMAN CELL; KIDNEY CELL; KIDNEY CLEARANCE; KIDNEY TUBULE ABSORPTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; WESTERN BLOTTING;

BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE; HUMANS; KIDNEY; MONOCARBOXYLIC ACID TRANSPORTERS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SODIUM OXYBATE; SYMPORTERS;

EID: 34249106145     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-006-9228-6     Document Type: Article

References (44)

1. R. H. Roth and N. J. Giarman. Natural occurrence of gamma-hydroxybutyrate in mammalian brain. Biochem. Pharmacol. 19:1087-1093 (1970).
2. S. P. Bessman and W. N. Fishbein. Gamma-hydroxybutyrate, a normal brain metabolite. Nature 200:1207-1208 (1963).
3. M. Maitre. The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Prog. Neurobiol. 51:337-361 (1997).
4. M. Mamelak, M. B. Scharf, and M. Woods. Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings. Sleep 9:285-289 (1986).
5. L. Gallimberti, M. R. Spella, C. A. Soncini, and G. L. Gessa. Gamma-hydroxybutyric acid in the treatment of alcohol and heroin dependence. Alcohol 20:257-262 (2000).
6. M. S. Okun, L. A. Boothby, R. B. Bartfield, and P. L. Doering. GHB: an important pharmacologic and clinical update. J. Pharm. Sci. 4:167-175 (2001).
7. C. G. Wong, K. M. Gibson, and O. C. Snead, 3rd. From the street to the brain: neurobiology of the recreational drug gamma-hydroxybutyric acid. Trends Pharmacol. Sci. 25:29-34 (2004).
8. P. E. Masonand and W. P. Kerns, 2nd. Gamma hydroxybutyric acid (GHB) intoxication. Acad. Emerg. Med. 9:730-739 (2002).
9. J. Lettieri and H. L. Fung. Improved pharmacological activity via pro-drug modification: comparative pharmacokinetics of sodium gamma-hydroxybutyrate and gamma-butyrolactone. Res. Commun. Chem. Pathol. Pharmacol. 22:107-118 (1978).
10. J. T. Lettieri and H. L. Fung. Dose-dependent pharmacokinetics and hypnotic effects of sodium gamma-hydroxybutyrate in the rat. J. Pharmacol. Exp. Ther. 208:7-11 (1979).
11. S. D. Ferrara, S. Zotti, L. Tedeschi, G. Frison, F. Castagna, L. Gallimberti, G. L. Gessa, and P. Palatini. Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. Br. J. Clin. Pharmacol. 34:231-235 (1992).
12. P. Palatini, L. Tedeschi, G. Frison, R. Padrini, R. Zordan, R. Orlando, L. Gallimberti, G. L. Gessa, and S. D. Ferrara. Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. Eur. J. Clin. Pharmacol. 45:353-356 (1993).
13. S. D. Ferrara, L. Tedeschi, G. Frison, R. Orlando, M. Mazzo, R. Zordan, R. Padrini, and P. Palatini. Effect of moderate or severe liver dysfunction on the pharmacokinetics of gamma-hydroxybutyric acid. Eur. J. Clin. Pharmacol. 50:305-310 (1996).
14. M. B. Scharf, A. A. Lai, B. Branigan, R. Stover, and D. B. Berkowitz. Pharmacokinetics of gammahydroxybutyrate (GHB) in narcoleptic patients. Sleep 21:507-514 (1998).
15. J. Lettieri and H. L. Fung. Absorption and first-pass metabolism of 14C-gamma-hydroxybutyric acid. Res. Commun. Chem. Pathol. Pharmacol. 13:425-437 (1976).
16. C. Arena and H. L. Fung. Absorption of sodium gamma-hydroxybutyrate and its prodrug gamma-butyrolactone: relationship between in vitro transport and in vivo absorption. J. Pharm. Sci. 69:356-358 (1980).
17. M. E. Morris, K. Hu, and Q. Wang. Renal clearance of gamma-hydroxybutyric acid in rats: increasing renal elimination as a detoxification strategy. J. Pharmacol. Exp. Ther. 313:1194-1202 (2005).
18. A. P. Halestrap and D. Meredith. The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch. 447:619-628 (2004).
19. A. P. Halestrap and N. T. Price. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem. J. 343(Pt 2):281-299 (1999).
20. R. Y. Lin, J. C. Vera, R. S. Chaganti, and D. W. Golde. Human monocarboxylate transporter 2 (MCT2) is a high affinity pyruvate transporter. J. Biol. Chem. 273:28959-28965 (1998).
21. C. K. Garcia, J. L. Goldstein, R. K. Pathak, R. G. Anderson, and M. S. Brown. Molecular characterization of a membrane transporter for lactate, pyruvate, and other monocarboxylates: implications for the Cori cycle. Cell 76:865-873 (1994).
22. C. Hadjiagapiou, L. Schmidt, P. K. Dudeja, T. J. Layden, and K. Ramaswamy. Mechanism(s) of butyrate transport in Caco-2 cells: role of monocarboxylate transporter 1. Am. J. Physiol.: Gastrointest. Liver Physiol. 279:G775-G780 (2000).
23. I. Tamai, Y. Sai, A. Ono, Y. Kido, H. Yabuuchi, H. Takanaga, E. Satoh, T. Ogihara, O. Amano, S. Izeki, and A. Tsuji. Immunohistochemical and functional characterization of pH-dependent intestinal absorption of weak organic acids by the monocarboxylic acid transporter MCT1. J. Pharm. Pharmacol. 51:1113-1121 (1999).
24. A. Okamura, A. Emoto, N. Koyabu, H. Ohtani, and Y. Sawada. Transport and uptake of nateglinide in Caco-2 cells and its inhibitory effect on human monocarboxylate transporter MCT1. Br. J. Pharmacol. 137:391-399 (2002).
25. S. A. Tsuji A, I. Tamai, and T. Terasaki. Transport mechanism of 3-hydroxy-3-methylglutaryl conenzyme A reductase inhibitors at the blood-brain barrier. J. Pharmacol. Exp. Ther. 267:1085-1090 (1993).
26. K. Nagasawa, K. Nagai, Y. Sumitani, Y. Moriya, Y. Muraki, K. Takara, N. Ohnishi, T. Yokoyama, and S. Fujimoto. Monocarboxylate transporter mediates uptake of lovastatin acid in rat cultured mesangial cells. J. Pharm. Sci. 91:2605-2613 (2002).
27. M. J. Ryan, G. Johnson, J. Kirk, S. M. Fuerstenberg, R. A. Zager, and B. Torok-Storb. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int. 45:48-57 (1994).
28. A. Bhandari, S. Koul, A. Sekhon, S. K. Pramanik, L. S. Chaturvedi, M. Huang, M. Menon, and H. K. Koul. Effects of oxalate on HK-2 cells, a line of proximal tubular epithelial cells from normal human kidney. J. Urol. 168:253-259 (2002).
29. J. C. Whitin, S. Bhamre, D. M. Tham, and H. J. Cohen. Extracellular glutathione peroxidase is secreted basolaterally by human renal proximal tubule cells. Am. J. Physiol. Renal Physiol. 283:F20-F28 (2002).
30. N. Romiti, G. Tramonti, and E. Chieli. Influence of different chemicals on MDR-1 P-glycoprotein expression and activity in the HK-2 proximal tubular cell line. Toxicol. Appl. Pharmacol. 183:83-91 (2002).
31. N. Romiti, G. Tramonti, A. Donati, and E. Chieli. Effects of grapefruit juice on the multidrug transporter P-glycoprotein in the human proximal tubular cell line HK-2. Life Sci. 76:293-302 (2004).
32. K. Balamurugan, N. D. Vaziri, and H. M. Said. Biotin uptake by human proximal tubular epithelial cells: cellular and molecular aspects. Am. J. Physiol. Renal Physiol. 288:F823-F831 (2005).
33. Q. Wang, Y. Lu, M. Yuan, I. Darling, E. Repasky, and M. Morris. Characterization of monocarboxylate transport in human kidney HK-2 Cells. Mol. Pharmacol. 3:675-685 (2006).
34. D. Kim, S. H. Garrett, M. A. Sens, S. Somji, and D. A. Sens. Metallothionein isoform 3 and proximal tubule vectorial active transport. Kidney Int. 61:464-472 (2002).
35. S. Zhang and M. Morris. Effect of the flavonoids biochanin A and silymarin on the P-glycoprotein-mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells. Pharm. Res. 20:1184-1191 (2003).
36. D. Eladari, R. Chambrey, T. Irinopoulou, F. Leviel, F. Pezy, P. Bruneval, M. Paillard, and R. A. Podevin. Polarized expression of different monocarboxylate transporters in rat medullary thick limbs of Henle. J. Biol. Chem. 274:28420-28426 (1999).
37. N. T. Price, V. N. Jackson, and A. P. Halestrap. Cloning and sequencing of four new mammalian monocarboxylate transporter (MCT) homologues confirms the existence of a transporter family with an ancient past. Biochem. J. 329(Pt 2):321-328 (1998).
38. M. J. Coady, M.-H. Chang, F. M. Charron, C. Plata, B. Wallendorff, J. F. Sah, S. D. Markowitz, M. F. Romero, and J.-Y. Lapointe. The human tumour suppressor gene SLC5A8 expresses a Na+-monocarboxylate cotransporter. J. Physiol. 557:719-731 (2004).
39. L. Carpenter and A. P. Halestrap. The kinetics, substrate and inhibitor specificity of the lactate transporter of Ehrlich-Lettre tumour cells studied with the intracellular pH indicator BCECF. Biochem. J. 304(Pt 3):751-760 (1994).
40. J. E. Manning Fox, D. Meredith, and A. P. Halestrap. Characterisation of human monocarboxylate transporter 4 substantiates its role in lactic acid efflux from skeletal muscle. J. Physiol. 529(Pt 2):285-293 (2000).
41. E. F. Grollman, N. J. Phlip, P. McPhie, R. D. Ward, and B. Sauer. Determination of transport kinetics of Chick MCT3 monocarboxylate transporter from retinal pigment epithelium by expression in genetically modified yeast. Biochemistry 39:9351-9357 (2000).
42. S. Broer, A. Broer, H. P. Schneider, C. Stegen, A. P. Halestrap, and J. W. Deitmer. Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes. Biochem. J. 341(Pt 3):529-535 (1999).
43. Q. Wang, I. M. Darling, and M. E. Morris. Transport of gamma-hydroxybutyrate in rat kidney membrane vesicles-Role of monocarboxylate transporters. J. Pharmacol. Exp. Ther. 318:751-761 (2006).
44. H. Li, L. Myeroff, D. Smiraglia, M. F. Romero, T. P. Pretlow, L. Kasturi, J. Lutterbaugh, R. M. Rerko, G. Casey, J. P. Issa, J. Willis, J. K. Willson, C. Plass, and S. D. Markowitz. SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers. Proc. Natl. Acad. Sci. U.S.A. 100:8412-8417 (2003).